Inventor · disambiguated record
Carlos Zarate
Also filed as: ZARATE CARLOS · ZARATE CARLOS A · ZARATE JR CARLOS A
8 granted patents·7 pending applications·119 citations·filing 2007–2025
88Inventor score
Files withUS HEALTH6ICAHN SCHOOL MED MOUNT SINAI5THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2CHARNEY DENNIS S1COOPER HEALTH SYSTEM1
Top patents by PatentIndex Score
15 records- 0193US9592207B2Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Mar 14, 2017·14 cites·15 claims
- 0293US8785500B2Intranasal administration of ketamine to treat depressionCHARNEY DENNIS S·Filed 2007·Granted Jul 22, 2014·55 cites·18 claims
- 0392US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0492US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0590US11613514B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2021·Granted Mar 28, 2023·2 cites·15 claims
- 0689US10919842B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2017·Granted Feb 16, 2021·4 cites·4 claims
- 0789US9539220B2Methods for treating suicidal ideationICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Jan 10, 2017·5 cites·9 claims
- 0877US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0975US12473251B2Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamineUS HEALTH·Filed 2023·Granted Nov 18, 2025·0 cites·3 claims
- 1069US2020253894A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2020·Application pending·0 cites
- 1168US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1265US2017151191A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Application pending·0 cites
- 1365US2017181966A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Application pending·0 cites
- 1459US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
- 1541US2019083420A1Methods of using (2r, 6r)-hydroxynorketamine and (2s, 6s)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, fatigue, suicidal ideation, and post traumatic stress disordersUS HEALTH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carlos Zarate files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →